Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (the “Company”)
today announced that Mr. Peter Greenleaf, Chief Executive Officer, will
present a corporate overview at the following upcoming investor
conferences:
-
Jefferies Healthcare Conference on Friday, June 7, 2019 at 9:30am PT
(12:30pm ET) in New York, NY; and
-
Raymond James 2019 Life Sciences and MedTech Conference on Tuesday,
June 18, 2019 at 5:35am (8:35am ET) in New York, NY.
All presentations will be webcast live and can be accessed via the
investor section of the Aurinia website, www.auriniapharma.com.
A replay of each presentation will also be archived on the Company
website following the event.
About Aurinia
Aurinia Pharmaceuticals Inc. is a late clinical stage
biopharmaceutical company focused on developing and commercializing
therapies to treat targeted patient populations impacted by serious
diseases with a high unmet medical need. The company is currently
developing voclosporin, an investigational drug, for the potential
treatment of lupus nephritis (LN), focal segmental glomerulosclerosis
(FSGS), and dry eye syndrome (DES). The company is headquartered in
Victoria, British Columbia and focuses its development efforts globally.
For further information, see our website at www.auriniapharma.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190604005957/en/
Copyright Business Wire 2019